-Sanofi Genzyme, the specialty care global business unit of Sanofi, and RNAi therapeutics company Alnylam Pharmaceuticals, Inc. announced Monday the.[...]
Press ReleaseSource: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi and Alnylam submit Marketing Authorization Application  to the European Medicines Agency for...[...]
Alnylam Pharmaceuticals (ALNY) and commercialization partner Sanofi Genzyme (SNY) announce the filing of a marketing application with the European Medicine[...]
Sanofi (SNY) and Alnylam announced that the FDA has lifted the clinical hold placed on all ongoing studies of its hemophilia candidate, fitusiran.[...]

45

Star ActiveStar ActiveStar ActiveStar ActiveStar Inactive
 
loading...